VENUNGOPAL, P., BALAKRISHNAN, K., SRIRAM, D. K., & GEORGE, M. (2022). INCLISIRAN (LEQVIO): A FIRST-IN-CLASS SMALL INTERFERING RNA THERAPEUTIC DRUG APPROVED BY FDA FOR TREATING PRIMARY HYPERCHOLESTEROLEMIA OR DYSLIPIDEMIA. Asian Journal of Pharmaceutical and Clinical Research, 15(12), 42–46. https://doi.org/10.22159/ajpcr.2022.v15i12.46054